Sweating The Little Things: European Companies Call On China to Overhaul Public Procurement System
This article was originally published in PharmAsia News
Executive Summary
They say misery loves company, so in one respect, biopharma and medical device companies can rest easy knowing that firms in seemingly every industry, from information technology firms to wind power equipment manufacturers, are struggling to make heads or tails of China's estimated $1 trillion public procurement market